Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,576 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
A phase I trial of concurrent chemoradiotherapy with non-split administration of docetaxel and cisplatin for dry stage III non-small-cell lung cancer (JCOG9901DI).
Hida N, Okamoto H, Misumi Y, Sato A, Ishii M, Kashizaki F, Shimokawa T, Shimizu T, Watanabe K. Hida N, et al. Among authors: ishii m. Cancer Chemother Pharmacol. 2012 Jun;69(6):1625-31. doi: 10.1007/s00280-012-1871-5. Epub 2012 May 8. Cancer Chemother Pharmacol. 2012. PMID: 22565592 Free PMC article. Clinical Trial.
Phase I/II study of induction chemotherapy using carboplatin plus irinotecan and sequential thoracic radiotherapy (TRT) for elderly patients with limited-disease small-cell lung cancer (LD-SCLC): TORG 0604.
Misumi Y, Okamoto H, Sasaki J, Masuda N, Ishii M, Shimokawa T, Hosomi Y, Okuma Y, Nagamata M, Ogura T, Kato T, Sata M, Otani S, Takakura A, Minato K, Miura Y, Yokoyama T, Takata S, Naoki K, Watanabe K. Misumi Y, et al. Among authors: ishii m. BMC Cancer. 2017 May 26;17(1):377. doi: 10.1186/s12885-017-3353-y. BMC Cancer. 2017. PMID: 28549414 Free PMC article. Clinical Trial.
Comparison of the efficacies of first-generation epidermal growth factor receptor tyrosine kinase inhibitors for brain metastasis in patients with advanced non-small-cell lung cancer harboring EGFR mutations.
Aiko N, Shimokawa T, Miyazaki K, Misumi Y, Agemi Y, Ishii M, Nakamura Y, Yamanaka T, Okamoto H. Aiko N, et al. Among authors: ishii m. BMC Cancer. 2018 Oct 22;18(1):1012. doi: 10.1186/s12885-018-4911-7. BMC Cancer. 2018. PMID: 30348116 Free PMC article.
Low-Dose Erlotinib Treatment in Elderly or Frail Patients With EGFR Mutation-Positive Non-Small Cell Lung Cancer: A Multicenter Phase 2 Trial.
Miyamoto S, Azuma K, Ishii H, Bessho A, Hosokawa S, Fukamatsu N, Kunitoh H, Ishii M, Tanaka H, Aono H, Nakahara Y, Kusaka K, Hosomi Y, Kikuchi N, Mori Y, Itani H, Hamada A, Yamada K, Okamoto H. Miyamoto S, et al. Among authors: ishii h, ishii m. JAMA Oncol. 2020 Jul 1;6(7):e201250. doi: 10.1001/jamaoncol.2020.1250. Epub 2020 Jul 9. JAMA Oncol. 2020. PMID: 32407455 Free PMC article. Clinical Trial.
Early pharmacodynamic assessment using ¹⁸F-fluorodeoxyglucose positron-emission tomography on molecular targeted therapy and cytotoxic chemotherapy for clinical outcome prediction.
Kanazu M, Maruyama K, Ando M, Asami K, Ishii M, Uehira K, Minomo S, Matsuda Y, Kawaguchi T, Atagi S, Ogawa Y, Kusunoki Y, Takada M, Kubo A. Kanazu M, et al. Among authors: ishii m. Clin Lung Cancer. 2014 May;15(3):182-7. doi: 10.1016/j.cllc.2014.01.001. Epub 2014 Jan 9. Clin Lung Cancer. 2014. PMID: 24518101 Clinical Trial.
Erector Spinae Muscle to Epicardial Visceral Fat Ratio on Chest CT Predicts the Severity of Coronavirus Disease 2019.
Shimada T, Maetani T, Chubachi S, Tanabe N, Asakura T, Namkoong H, Tanaka H, Azekawa S, Otake S, Nakagawara K, Fukushima T, Watase M, Shiraishi Y, Terai H, Sasaki M, Ueda S, Kato Y, Harada N, Suzuki S, Yoshida S, Tateno H, Shimizu K, Sato S, Yamada Y, Jinzaki M, Hirai T, Okada Y, Koike R, Ishii M, Kimura A, Imoto S, Miyano S, Ogawa S, Kanai T, Fukunaga K. Shimada T, et al. Among authors: ishii m. J Cachexia Sarcopenia Muscle. 2025 Feb;16(1):e13721. doi: 10.1002/jcsm.13721. J Cachexia Sarcopenia Muscle. 2025. PMID: 39868664
3,576 results